Literature DB >> 24251009

The Relationship between Coronary Artery Movement Type andStenosis Severity with Acute Myocardial Infarction.

Samad Ghaffari1, Siamak Erfanparast, Ahmad Separham, Sepideh Sokhanvar, Mehrdad Yavarikia, Leili Pourafkari.   

Abstract

INTRODUCTION: The severity of coronary artery stenosis which leads to myocardial infarction (MI) has been a matter of controversy. Historical data are in favor of mild luminal stenosis (<50% diameter stenosis) while recent studies suggest hemodynamically-significant coronary stenosis as the main substrate for subsequent MI. Also, mechanical stress resulted from coronary artery movement (CAM) may be responsible for plaques rupture. In this study, we evaluated the severity of plaques leading to MI and common CAM patterns in the involved coronary segments.
METHODS: In a cross-sectional descriptive-analytical study, on patients with acute ST-segment myocardial infarction (STEMI) undergoing coronary angiography, the relationship between coronary artery movement type and stenosis severity with acute MI was evaluated. Lesions with stenosis diameter greater than 50 percent were defined as moderate and those equal or higher than 70% were defined as severe stenosis. Three different patterns of coronary artery motion including compression, bending and displacement types were evaluated in segments with culprit lesion.
RESULTS: One hundred and sixty two patients were enrolled. Ninety patients (55.6%) were male and 72 (44.4%) were female. Mean age of the patients was 60.56±13.43 years. In terms of Infarct related lesions (IRLs), 86% of the cases had at least moderate stenosis and in 67%, severe stenosis was present. More than 50% stenosis was found in all patients with anterior STEMI involving LAD. Among three types of coronary motion patterns, compression pattern was significantly higher in LAD (P<0.001), RCA (P<0.001), Diagonal artery (P<0.001) and OM branch (P=0.044), but not in proper LCX (P=0.307).
CONCLUSION: Most of the lesions leading to myocardial infarction have a diameter stenosis of at least 50% and mainly are located in the coronary segments with compression movement pattern.

Entities:  

Keywords:  Coronary Artery Movement; Coronary Plaque; Myocardial Infarction

Year:  2013        PMID: 24251009      PMCID: PMC3825389          DOI: 10.5681/jcvtr.2013.009

Source DB:  PubMed          Journal:  J Cardiovasc Thorac Res        ISSN: 2008-5117


  12 in total

1.  Patterns of coronary artery movement and the development of coronary atherosclerosis.

Authors:  Tsuyoshi Konta; John Hugh Nicholas Bett
Journal:  Circ J       Date:  2003-10       Impact factor: 2.993

2.  Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography.

Authors:  D Giroud; J M Li; P Urban; B Meier; W Rutishauer
Journal:  Am J Cardiol       Date:  1992-03-15       Impact factor: 2.778

3.  Is a myocardial infarction more likely to result from a mild coronary lesion or an ischemia-producing one?

Authors:  William F Fearon
Journal:  Circ Cardiovasc Interv       Date:  2011-12-01       Impact factor: 6.546

4.  The relationship between coronary stenosis severity and compression type coronary artery movement in acute myocardial infarction.

Authors:  Kim H Chan; Chirapan Chawantanpipat; Tim Gattorna; Thamarath Chantadansuwan; Adrienne Kirby; Ann Madden; Anthony Keech; Martin K C Ng
Journal:  Am Heart J       Date:  2010-04       Impact factor: 4.749

5.  Angiographic progression of coronary artery disease and the development of myocardial infarction.

Authors:  J A Ambrose; M A Tannenbaum; D Alexopoulos; C E Hjemdahl-Monsen; J Leavy; M Weiss; S Borrico; R Gorlin; V Fuster
Journal:  J Am Coll Cardiol       Date:  1988-07       Impact factor: 24.094

6.  Considerable time from the onset of plaque rupture and/or thrombi until the onset of acute myocardial infarction in humans: coronary angiographic findings within 1 week before the onset of infarction.

Authors:  S Ojio; H Takatsu; T Tanaka; K Ueno; K Yokoya; T Matsubara; T Suzuki; S Watanabe; N Morita; M Kawasaki; T Nagano; I Nishio; K Sakai; K Nishigaki; G Takemura; T Noda; S Minatoguchi; H Fujiwara
Journal:  Circulation       Date:  2000-10-24       Impact factor: 29.690

7.  Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?

Authors:  W C Little; M Constantinescu; R J Applegate; M A Kutcher; M T Burrows; F R Kahl; W P Santamore
Journal:  Circulation       Date:  1988-11       Impact factor: 29.690

8.  A contemporary re-evaluation of culprit lesion severity in patients presenting with STEMI.

Authors:  Liam M McCormick; Stephen P Hoole; Adam J Brown; David P Dutka; Nick E J West
Journal:  Acute Card Care       Date:  2012-12

9.  Dobutamine-induced ST-segment elevation associated with a biphasic response of wall motion in patients with a recent myocardial infarction is caused by myocardial ischaemia and is abolished by revascularization of the infarct-related artery.

Authors:  Luca Lanzarini; Laura Scelsi; Umberto Canosi; Catherine Klersy; Roberta Sebastiani; Mario Previtali
Journal:  Acta Cardiol       Date:  2003-12       Impact factor: 1.718

10.  The stretch-compression type of coronary artery movement predicts the location of culprit lesions responsible for ST-segment elevation myocardial infarctions.

Authors:  Aiden J C O'Loughlin; Karen Byth
Journal:  Heart Lung Circ       Date:  2007-06-19       Impact factor: 2.975

View more
  2 in total

1.  Coronary Atherosclerotic Plaque Vulnerability Rather than Stenosis Predisposes to Non-ST Elevation Acute Coronary Syndromes.

Authors:  Mohamed Laimoud; Farouk Faris; Helmy Elghawaby
Journal:  Cardiol Res Pract       Date:  2019-03-11       Impact factor: 1.866

2.  CircSLC8A1 and circNFIX can be used as auxiliary diagnostic markers for sudden cardiac death caused by acute ischemic heart disease.

Authors:  Meihui Tian; Jiajia Xue; Cuiyun Dai; Enzhu Jiang; Baoli Zhu; Hao Pang
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.